The USFDA has stated that it may withhold approval of any pending
applications or supplements in which this facility is listed," it
added.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupins-goa-facility-may-face-regulatory-action-says-usfda/articleshow/69586425.cms
No comments:
Post a Comment